Overview
Prophylactic Quetiapine on Delirium Prevention in Critically Ill Patients
Status:
Unknown status
Unknown status
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to evaluate the efficacy of low dose quetiapine for the prophylaxis of delirium in critically ill patients in medical intensive care unit.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Seoul National University HospitalTreatments:
Quetiapine Fumarate
Criteria
Inclusion Criteria:- Greater than or equal to 19 years of age, admitting to medical ICU, anticipated to
stay more than 72hours
Exclusion Criteria:
- Female patients who are pregnant or breastfeeding
- active delirium
- Received other anti-psychotic drug before attend the study
- severe bradycardia
- alcohol intoxication
- No written consent from the legal representatives
- Being ill with renal or hepatic failure